Missing piece in Crohn’s disease is discovered—immune cells that vanish before symptoms even start! This groundbreaking ...

Crohn's disease belongs to a group of conditions known as inflammatory bowel diseases (IBD). This chronic condition causes ...

Researchers uncover cellular pathways linked to inflammatory bowel disease onset, offering insights for new therapies to ...

A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease ...

A team of scientists has discovered mechanisms of abnormal immune cell function that may lead to Crohn’s disease, an ...

New study shows that dysfunction of protective immune cells in GI tract may contribute to onset of inflammation in Crohn's disease.

A team of scientists has discovered mechanisms of abnormal immune cell function that may lead to Crohn’s disease, an ...

The Food and Drug Administration (FDA) has approved Tremfya ® (guselkumab) for the treatment of adults with moderately to severely active Crohn disease (CD).

AND WHAT ARE THE SYMPTOMS? PEOPLE WITH CROHN’S DISEASE MAY HAVE DIARRHEA, STOMACH PAIN, NAUSEA, FEVER, AND WEIGHT LOSS. SOME MAY FEEL VERY TIRED OR LOSE THEIR APPETITE. SYMPTOMS CAN COME AND GO ...

The FDA has approved guselkumab (Tremfya) as the first IL-23 inhibitor offering both subcutaneous and intravenous induction ...